Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function
Cardiovascular Research · 04.07.2023 · 119 (7) · 1537-1552
DOI: 10.1093/cvr/cvad041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 06.03.2023. Verfasst von Marion Laudette und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothen…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Proprotein Convertase 9. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Fondazione Cariplo.
Abstract (Originalsprache)
Aims
Pro-protein convertase subtilisin-kexin type 9 (PCSK9), which is expressed mainly in the liver and at low levels in the heart, regulates cholesterol levels by directing low-density lipoprotein receptors to degradation. Studies to determine the role of PCSK9 in the heart are complicated by the close link between cardiac function and systemic lipid metabolism. Here, we sought to elucidate the function of PCSK9 specifically in the heart by generating and analysing mice with cardiomyocyte-specific Pcsk9 deficiency (CM-Pcsk9−/− mice) and by silencing Pcsk9 acutely in a cell culture model of adult cardiomyocyte-like cells. Methods and results Mice with cardiomyocyte-specific deletion of Pcsk9 had reduced contractile capacity, impaired cardiac function, and left ventricular dilatation at 28 weeks of age and died prematurely. Transcriptomic analyses revealed alterations of signalling pathways linked to cardiomyopathy and energy metabolism in hearts from CM-Pcsk9−/− mice vs. wild-type littermates. In agreement, levels of genes and proteins involved in mitochondrial metabolism were reduced in CM-Pcsk9−/− hearts. By using a Seahorse flux analyser, we showed that mitochondrial but not glycolytic function was impaired in cardiomyocytes from CM-Pcsk9−/− mice. We further showed that assembly and activity of electron transport chain (ETC) complexes were altered in isolated mitochondria from CM-Pcsk9−/− mice. Circulating lipid levels were unchanged in CM-Pcsk9−/− mice, but the lipid composition of mitochondrial membranes was altered. In addition, cardiomyocytes from CM-Pcsk9−/− mice had an increased number of mitochondria–endoplasmic reticulum contacts and alterations in the morphology of cristae, the physical location of the ETC complexes. We also showed that acute Pcsk9 silencing in adult cardiomyocyte-like cells reduced the activity of ETC complexes and impaired mitochondrial metabolism.
Conclusion
PCSK9, despite its low expression in cardiomyocytes, contributes to cardiac metabolic function, and PCSK9 deficiency in cardiomyocytes is linked to cardiomyopathy, impaired heart function, and compromised energy production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden.
- Science for Life Laboratory, Royal Institute of Technology, Stockholm 17165, Sweden.
- Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg 40530, Sweden.
- Faculty of Dentistry, Oral & Craniofacial Sciences, Centre for Host-Microbiome Interactions, King's College London, London WC2R 2L2, UK.
- Department of Cardiology, Sahlgrenska University Hospital, Gothenburg 41345, Sweden.
- William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK.
ORCID-Profile: Muhammad Arif, Mathieu Cinato, Stephen Doran, Marcus Henricsson, Nay Aung, Tuulia Hyötyläinen, Jan Borén
Förderung
- Swedish Research Council
- Fondazione Cariplo
Zitieren
APA
Laudette, M., Lindbom, M., Arif, M., Cinato, M., Ruiz, M., Doran, S., Miljanovic, A., Rutberg, M., Andersson, L., Klevstig, M., Henricsson, M., Bergh, P. O., Bollano, E., Aung, N., Gustav Smith, J., Pilon, M., Hyötyläinen, T., Orešič, M., Perkins, R., …, & Borén, J. (2023). Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function. Cardiovascular Research, 119(7), 1537-1552. https://doi.org/10.1093/cvr/cvad041
Vancouver
Laudette M, Lindbom M, Arif M, Cinato M, Ruiz M, Doran S, et al. Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function. Cardiovascular Research. 2023;119(7):1537-1552. doi:10.1093/cvr/cvad041
BibTeX
@article{Laudette2023,
author = {Laudette, Marion and Lindbom, Malin and Arif, Muhammad and Cinato, Mathieu and Ruiz, Mario and Doran, Stephen and Miljanovic, Azra and Rutberg, Mikael and Andersson, Linda and Klevstig, Martina and Henricsson, Marcus and Bergh, Per-Olof and Bollano, Entela and Aung, Nay and Gustav Smith, J and Pilon, Marc and Hyötyläinen, Tuulia and Orešič, Matej and Perkins, Rosie and Mardinoglu, Adil and Levin, Malin C and Borén, Jan},
title = {Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {7},
pages = {1537--1552},
doi = {10.1093/cvr/cvad041}
}
EUVIMED